share_log

白云山(600332.SH):子公司药品通过仿制药一致性评价

Baiyunshan (600332.SH): Subsidiaries' pharmaceutical products pass the evaluation of generic drug consistency.

Gelonghui Finance ·  Aug 23 04:34

GeLonghui August 23rd | Baiyunshan (600332.SH) announced that its holding subsidiary Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. (referred to as "Tianxin Pharmaceutical") has received the "Drug Supplementary Application Approval Notice" issued by the National Medical Products Administration. The injection of Cefpirome Hydrochloride (0.5g, 1.0g) has passed the generic drug quality and efficacy consistency evaluation. Cefpirome is a fourth-generation cephalosporin antibiotic, which can be used to treat moderate to severe infections caused by sensitive bacteria in adults and children aged 2 months to 16 years old.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment